Lyme disease, caused by the spirochete Borrelia burdofgeri, is the most common vector-borne illness reported in the U.S. Cases occur mainly in the Northeast, Mid-Atlantic and upper Midwest as well as certain areas of the Pacific coast, with a geographic distribution based on residence of Ixodes scapularis (Ixodes pacificus on the West Coast), the vectors that transmits Lyme disease.
Lancet reports that a common surgical intervention, arthroscopic sub-acromial decompression is ineffective compared to arthroscopy or no surgery at all.
Researchers from the University of Birmingham have shown that while Vitamin D may be effective at preventing the onset of inflammation, it is less effective once inflammatory disease is established - largely because, once established, rheumatoid arthritis leads to vitamin D insensitivity. (Citation source https://buff.ly/2iGHYmI)
Reuters reports that the opioid crisis has cost the United States as much as $504 billion in 2015, based on a White House economists report released this week. The White House Council of Economic Advisers (CEA) said the toll from the opioid crisis represented 2.8% of gross domestic product that year.
The Annual Meeting of the American College of Rheumatology is a gargantuan educational and professional event that is on nearly everyone's radar each year. RheumNow had an expansive effort to cover this meeting and you can review the work of our faculty at ACR17.RheumNow.com. But we have decided to take this one step further and today we are announcing our 2017 RheumNow ACR Awards.
The American College of Rheumatology opened the 2017 meeting by inducting the new president (Dr. David Daikh) and officers and announcing its 2017 Award Winners. These recognitions are given annually to members who exhibit outstanding contributions to the field of rheumatology.
Dr. Kathryn Dao: Lupus SynBiose Study - RTX Followed by Belimumab Therapy
Dr. Kathryn Dao discusses abstract 890 as presented at the ACR/ARHP Annual Meeting in San Diego.
Dr. Janet Pope: Top 5 Take Home Messages in Lupus, RA and Big Data
Dr. Janet Pope discusses big data, RA and lupus take-home messages from the ACR/ARHP Annual Meeting in San Diego.
Dr. Rachel Tate: Sarcoidosis and TNF Inhibitors
Dr. Rachel Tate discusses abstract 2904 presented at the ACR/ARHP Annual Meeting in San Diego.
The following is a collection of AS/SpA-specific mentions culled from RheumNow's coverage of the Annual ACR 2017 meeting in San Diego.
Visit our RheumNow annual meeting site to read our gout content - http://acr17.rheumnow.com/category/gout-crystal/
Specific items:
Patients and physicians are riddled with misconceptions when pregnancy is concerned. As construed by Dr. Jack Cush, most rheumatologists treat pregnancy like a cancer and avoid the gravid patient, deferring to obstetricians who do not have training in rheumatology to manage the rheumatic condition as well as the pregnancy.
Dr. Paul Emery ACR17 - Microarray Pathways in Baricitinib vs Adalimumab Treated RA
For more on this presentation https://buff.ly/2zkxALQ
Dr. Ian Bruce at ACR 17 - Maintenance of Remission in Systemic Vasculitis
For more on this presenation https://buff.ly/2zluYxi
Dr. Jack Cush and Rheumatology Winter Clinical Symposium
Dr. Cush invites you to attend the Rheumatology Winter Clinical Symposium Feb. 7 - 10, 2018. For more information visit https://r-w-c-s.com/2018/.
Reuters reports that a federal jury has ordered Johnson & Johnson and its DePuy Orthopaedics division to pay $247 million settlment to six patients who suffered from its defective Pinnacle, metal-on-metal, hip implants. in the US. J&J says it will appeal this decision.These implants were associated with tissue necrosis, bone erosion and other injuries due to implant design.

